Effect of Transcutaneous Electrical Nerve Stimulation on Post-stroke Patients

NCT ID: NCT06541015

Last Updated: 2025-08-13

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 100 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2019-06-21
• Study Completion Date: 2025-12-31

Brief Summary

The subjects will be asked to attend minimum 15 separate sessions, 6 for testing changes in reflex behaviors, 3 for testing changes in the influence of descending motor tracts on spinal motor neurons, 3 for each testing functional movement in response to a trip event and cross-tilt walking adaptation pattern, as part of their participation in the research study. The estimated amount of time to enroll and collect the data for each of the subjects is four months' time. The data will be analyzed and ready for grant preparation (if successful) in approximately four months after the start of the study.

Detailed Description

The subjects will be asked to attend minimum 15 separate sessions, 6 for testing changes in reflex behaviors, 3 for testing changes in the influence of descending motor tracts on spinal motor neurons, 3 for each testing functional movement in response to a trip event and cross-tilt walking adaptation pattern, as part of their participation in the research study. During the first session, the subjects will be screened and informed about the research study, so they can consent to their participation. They will also be oriented to the lab, the equipment, as well as the research team. Following the orientation, the remaining time will consist of approximately 3 hours of data collection. The remaining will last approximately 3 hours and consist of the completion of data collection. Additional sessions after 15 sessions will be optional and will be reserved for completing data collection if the subject is unable to complete a trial session or to analyze for test retest variability within the subject population. The estimated amount of time to enroll and collect the data for each of the subjects is four months' time. The data will be analyzed and ready for grant preparation (if successful) in approximately four months after the start of the study.

Conditions

Hemiplegia and/or Hemiparesis Following Stroke; Anterior Circulation Stroke of Uncertain Pathology

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: BASIC_SCIENCE
• Blinding Strategy: NONE

Study Groups

Post Stroke - individuals with history of single unilateral stroke (>6 months since onset)

Individuals, aged 18-80, male or female, with a history of single unilateral stroke with subsequent lower limb hemiparesis on either side (\>6 months since onset)

Group Type: EXPERIMENTAL

InTENSity 10 TENS Stimulator

Intervention Type: DEVICE

InTENSity 10 TENS stimulator is a portable electrotherapy device featuring Transcutaneous Electrical Nerve Stimulation (TENS) therapeutic device. The stimulator sends a gentle electrical current to underlying nerves and muscle group via electrodes applied on the skin. The parameters of device are controlled by the buttons.

Interventions

InTENSity 10 TENS Stimulator

InTENSity 10 TENS stimulator is a portable electrotherapy device featuring Transcutaneous Electrical Nerve Stimulation (TENS) therapeutic device. The stimulator sends a gentle electrical current to underlying nerves and muscle group via electrodes applied on the skin. The parameters of device are controlled by the buttons.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• History of single unilateral stroke with subsequent lower limb hemiparesis on either side (> 6 months since onset)
• Ability to walk as part of activities of daily living
• Age between 18 and 80

• No history of stroke, cerebral palsy, injury or surgery to the lower limb.
• Currently not taking any central nervous system (CNS) affecting medication.
• Ability to walk as part of activities of daily living
• Age between 18 and 80

Exclusion Criteria

• Presence of concurrent severe medical illness including unhealed pressure sore, active or untreated infection, thromboembolic disease, severe contracture, osteoporosis, heterotropic classification, lower limb fracture, severe pulmonary disease or cardiovascular instability, uncontrolled seizure, uncontrolled diabetes
• History of any neurological injury other than a single stroke
• Has received a Botox injection in the lower extremity within the last 4 months
• Any cognitive deficit that would prevent informed consent or ability to perform the experiment
• History of prior injury or surgery to the hip or knee
• Presence of significant lower extremity edema - Presence of cardiac pacemaker or any other electrically implanted device - Use of braces limiting harness/Lokomat fit (Any spinal orthoses such as TLSO, HALO)
• Weight greater than 300 pounds
• Adults unable to consent, infants, children, teenagers, pregnant women and prisoners will not be included in the study
• Clinically significant depression, psychiatric disorders, or ongoing drug abuse
• Actively taking medications with agents known to increase (e.g. amphetamines) or decrease motor system excitability
• Suffered a concussion in the last 6 months.
• Unexplained headaches

Healthy Cohort:

• Presence of concurrent severe medical illness including unhealed pressure sore, active or untreated infection, thromboembolic disease, severe contracture, osteoporosis, heterotropic classification, lower limb fracture, severe pulmonary disease or cardiovascular instability, uncontrolled seizure, uncontrolled diabetes
• History of any neurological injury
• Taking any medication affecting change in CNS
• Any cognitive deficit that would prevent informed consent or ability to perform the experiment
• History of prior injury or surgery to the hip or knee
• Presence of significant lower extremity edema - Presence of cardiac pacemaker or any other electrically implanted device - Use of braces limiting harness/Lokomat fit (Any spinal orthoses such as TLSO, HALO)
• Weight greater than 300 pounds
• Adults unable to consent, infants, children, teenagers, pregnant women and prisoners will not be included in the study
• Clinically significant depression, psychiatric disorders, or ongoing drug abuse
• Actively taking medications with agents known to increase (e.g. amphetamines) or decrease motor system excitability
• Suffered a concussion in the last 6 months.
• Unexplained headaches
• Has received a Botox injection in the lower extremity within the last 4 months

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

University of Texas Southwestern Medical Center

OTHER

Sponsor Role: lead

Responsible Party

Yasin Dhaher

Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Yasin Dhaher, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Texas Southwestern Medical Center

Locations

University of Texas Medical Center

Dallas, Texas, United States

Site Status: RECRUITING

Countries

United States

Central Contacts

Yasin Dhaher, Ph.D.

Role: CONTACT

yasin.dhaher@utsoutwestern.edu

214-645-0064

Yu-Chen Chung, Ph.D.

Role: CONTACT

yu-chen.chung@utsouthwestern.edu

214-648-8838

Facility Contacts

Yasin Dhaher, Ph.D.

Role: primary

yasin.dhaher@utsoutwestern.edu

214-645-0064

Yu-Chen Chung, Ph.D.

Role: backup

yu-chen.chung@utsouthwestern.edu

214-648-8838

Other Identifiers

STU-2018-0431

Identifier Type: -

Identifier Source: org_study_id